| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
|---|
| Research Abstract |
Previously, we reported that <sup>11</sup>C-labeled ketoprofen-methyl ester (KTP-Me), a derivative of COX-1 selective inhibitor, could visualize the activation of microglia in rat model of neuroinflammation. In order to assess the hypothesis that COX-1 may play a crucial role in neuroinflammation, we evaluated the involvement of COX-1 in neuronal damages after transient middle cerebral artery occlusion (t-MCAO) in mice and rats. PET images with [<sup>11</sup>C]KTP-Me were well correlated with the time-dependent changes of activated microglia in ischemic region after t-MCAO. The studies using COX-1 knockout mice revealed that the deficiency of COX-1 reduced neuroinflammation but exacerbated neurotoxicity induced by t-MCAO. These results raise the possibility that COX-1 may be involved in the neuroprotective functions after focal cerebral ischemia.
|
